* Identified knockdown of target genes for the NASH treatment candidate * Reduction of ALT and A...
SUWON, South Korea, May 9, 2019 /PRNewswire/ -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a lea...
